Daily Stormer The Most Censored Publication in History
“I don’t trust you to inject me with THAT – but sure, you can inject me with this.”
Hmmm.
Germany will offer its population a new protein-based Covid-19 vaccine comparable to conventional flu jabs this week, in the hope of swaying a sizeable minority that remains sceptical of the novel mRNA technology used in the most commonly used vaccines.
About 1.4m doses of the Nuvaxovid vaccine developed by the US biotech company Novavax are to arrive in Germany this week, the country’s health minister, Karl Lauterbach, confirmed last Friday. A further million doses are to arrive the week after, with the German government’s total order for the year 2022 amounting to 34m doses.
Novavax’s product has until now been used only in Indonesia and the Philippines, but it was permitted for use in the EU last December. It is still awaiting authorisation in the US, as some concerns about the company’s production capacity persist.
Unlike the novel mRNA vaccines produced by Pfizer/BioNTech and Moderna or viral vector made by AstraZeneca and Johnson & Johnson, Nuvaxovid is a protein subunit vaccine. It contains a non-infectious component on the surface of the Sars-CoV-2 virus, which induces a protective immune response when the body’s immune cells come into contact with it.
Novavax announced in June last year that its vaccine had proven more than 90% effective against symptomatic infections with the Alpha variant, in trials including nearly 30,000 volunteers in the US and Mexico.
I keep hearing from right-wing media that the pandemic is over forever, yet here we are with new vaccines.
I also heard that non-mRNA vaccines cannot possibly be effective, because they don’t produce enough of the health-strengthening spike proteins.
